Nuvalent Ownership | Who Owns Nuvalent?
Nuvalent Ownership Summary
Nuvalent is owned by 10.76% institutional investors, 2.76% insiders, and 86.48% retail investors. Deerfield management company, l.p. (series c) is the largest institutional shareholder, holding 22.96% of NUVL shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 3.52% of its assets in Nuvalent shares.
NUVL Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Nuvalent | 10.76% | 2.76% | 86.48% |
| Sector | Healthcare Stocks | 35.70% | 12.04% | 52.26% |
| Industry | Biotech Stocks | 35.48% | 11.92% | 52.60% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Deerfield management company, l.p. (series c) | 17.25M | 22.96% | $1.77B |
| Fmr | 9.27M | 12.35% | $950.22M |
| Vanguard group | 5.24M | 7.27% | $527.52M |
| Paradigm biocapital advisors lp | 5.32M | 7.09% | $545.49M |
| Blackrock funding, inc. /de | 4.82M | 6.42% | $494.30M |
| Blackrock | 3.02M | 4.71% | $229.37M |
| Jpmorgan chase | 3.09M | 4.11% | $298.71M |
| Ra capital management | 2.53M | 3.37% | $259.62M |
| Wellington management group llp | 2.47M | 3.29% | $253.10M |
| Price t rowe associates inc /md/ | 2.06M | 2.74% | $210.65M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Deerfield management company, l.p. (series c) | 17.25M | 20.85% | $1.77B |
| Paradigm biocapital advisors lp | 5.32M | 11.15% | $545.49M |
| Commodore capital lp | 833.60K | 4.94% | $85.40M |
| Fny investment advisers | 108.95K | 4.84% | $13.46M |
| Boxer capital | 1.12M | 4.48% | $84.98M |
| First turn management | 370.34K | 4.24% | $37.94M |
| Silverarc capital management | 354.91K | 3.71% | $36.36M |
| Perceptive advisors | 1.58M | 3.17% | $161.92M |
| Ra capital management | 2.53M | 2.75% | $259.62M |
| Bellevue group | 1.05M | 2.57% | $107.91M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deep track capital, lp | 1.38M | 2.30% | 1.38M |
| Jpmorgan chase | 3.09M | 0.02% | 883.10K |
| Ra capital management | 2.53M | 2.75% | 654.09K |
| Vanguard group | 5.24M | 0.01% | 639.26K |
| Norges bank | 574.24K | 0.01% | 574.24K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Fmr | 9.27M | 0.05% | -1.58M |
| Bain capital life sciences investors | - | - | -1.45M |
| Darwin global management | - | - | -1.44M |
| Fairmount funds management | - | - | -727.56K |
| Logos global management lp | - | - | -500.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Deep track capital, lp | 1.38M | 2.30% | 1.38M | $141.00M |
| Norges bank | 574.24K | 0.01% | 574.24K | $57.76M |
| Vanguard fiduciary trust | 364.17K | 0.01% | 364.17K | $37.31M |
| Fny investment advisers | 108.95K | 4.84% | 108.95K | $13.46M |
| Two sigma investments, lp | 102.12K | 0.01% | 102.12K | $10.46M |
Sold Out
| Holder | Change |
|---|---|
| Td private client wealth | -1.00 |
| Dunhill financial | -1.00 |
| Financial gravity asset management | -1.00 |
| Sbi securities | -3.00 |
| Ronald blue trust | -4.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 103 | -56.90% | 8,085,732 | -89.88% | 10 | 0.09% | 60 | -62.96% | 22 | -52.17% |
| Dec 31, 2025 | 163 | -19.70% | 23,806,487 | -67.13% | 32 | 0.32% | 117 | 17.00% | 24 | -60.66% |
| Sep 30, 2025 | 197 | -10.05% | 71,933,593 | 0.06% | 100 | 1.00% | 98 | -20.97% | 60 | 7.14% |
| Jun 30, 2025 | 218 | 1.87% | 71,878,154 | -0.07% | 100 | 0.99% | 123 | 19.42% | 56 | -24.32% |
| Mar 31, 2025 | 17 | -92.58% | 31,565,284 | -55.28% | 44 | 0.38% | 7 | -95.17% | 7 | -85.71% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl O | 2.49M | 3.52% | - |
| Vanguard Total Stock Mkt Idx Inv | 1.75M | 2.22% | 5.84K |
| Vanguard Small Cap Index | 1.26M | 1.60% | -2.52K |
| iShares Russell 2000 ETF | 1.20M | 1.53% | 11.08K |
| Vanguard Health Care Inv | 1.05M | 1.33% | - |
| Polar Capital Biotech S Inc | 964.07K | 1.22% | - |
| State Street® SPDR® S&P® Biotech ETF | 937.41K | 1.20% | -5.78K |
| Strategic Advisers Fidelity US TtlStk | 844.55K | 1.08% | - |
| Fidelity Growth Company Fund | 833.28K | 1.06% | -380.00K |
| Fidelity Growth Compy Commingled Pl S | 820.28K | 1.05% | -554.59K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 09, 2026 | Pelish Henry E. | Chief Scientific Officer | Sell | $261.36K |
| Jul 06, 2026 | Porter James Richard | President and CEO | Sell | $3.71M |
| Jul 01, 2026 | Noci Darlene | Chief Development Officer | Sell | $2.84M |
| Jul 01, 2026 | Balcom Alexandra | Chief Financial Officer | Sell | $1.41M |
| Jun 29, 2026 | Noci Darlene | Chief Development Officer | Sell | $679.30K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | 4 |
| 2026 Q2 | - | 36 |
| 2026 Q1 | - | 75 |
| 2025 Q4 | - | 68 |
| 2025 Q3 | - | 32 |
NUVL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools